Haisco Pharmaceutical Group Co., Ltd. (SHE: 002653)

Haisco Pharmaceutical Group Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Nov 14, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020	Dec 31, 2019
Market Capitalization	36,217	25,545	23,695	21,747	18,638	21,777
Market Cap Growth	59.17%	7.81%	8.96%	16.68%	-14.41%	71.24%
Enterprise Value	36,993	26,256	25,227	22,521	19,066	22,271
Last Close Price	32.65	22.90	22.01	19.94	16.89	19.56
PE Ratio	75.57	84.80	84.64	62.32	28.63	42.51
Forward PE	57.15	60.57	69.53	62.77	23.76	44.73
PS Ratio	9.67	7.61	7.86	7.84	5.60	5.53
PB Ratio	8.85	6.13	7.56	7.45	6.53	9.16
P/TBV Ratio	13.91	7.45	10.18	10.07	8.10	10.62
P/FCF Ratio	374.12	436.15	-	-	-	119.93
P/OCF Ratio	79.51	56.82	250.62	607.43	90.39	28.49
EV/Sales Ratio	9.94	7.83	8.37	8.12	5.73	5.66
EV/EBITDA Ratio	59.45	52.01	79.50	122.44	57.27	54.20
EV/EBIT Ratio	97.35	89.00	178.20	598.98	83.50	68.95
EV/FCF Ratio	382.13	448.29	-	-	-	122.65
Debt / Equity Ratio	0.50	0.43	0.67	0.43	0.38	0.45
Debt / EBITDA Ratio	3.33	3.53	6.48	6.55	3.23	2.63
Debt / FCF Ratio	21.42	30.84	-	-	-	5.95
Asset Turnover	0.57	0.53	0.55	0.55	0.66	0.84
Inventory Turnover	3.50	3.10	3.05	3.91	5.17	7.98
Quick Ratio	1.72	1.50	1.09	0.81	1.04	0.73
Current Ratio	1.99	1.76	1.38	1.02	1.22	0.83
Return on Equity (ROE)	13.22%	8.09%	12.94%	17.93%	22.98%	21.73%
Return on Assets (ROA)	3.62%	2.90%	1.60%	0.47%	2.85%	4.29%
Return on Capital (ROIC)	3.98%	3.29%	1.88%	0.58%	3.86%	6.32%
Earnings Yield	1.32%	1.16%	1.17%	1.59%	3.42%	2.27%
FCF Yield	0.27%	0.23%	-2.56%	-3.07%	-2.12%	0.83%
Dividend Yield	0.86%	0.87%	-	0.93%	2.20%	0.47%
Payout Ratio	88.72%	14.43%	89.32%	123.52%	20.54%	48.35%
Buyback Yield / Dilution	-1.13%	-2.57%	1.17%	0.07%	-0.50%	0.12%
Total Shareholder Return	-0.27%	-1.69%	1.17%	0.99%	1.71%	0.59%

Source: S&P Capital IQ. Standard template. Financial Sources.